OraSure Technologies | OSUR - Bruttoergebnis Vom Umsatz

Aktienkurs
3.09
Täglich Wechseln
0.13 4.22%
Monatlich
-1.44%
Jährlich
2.83%
Q2 Prognose
2.88




Bruttoergebnis Vom Umsatz Veränderung Datum
Agilent USD 946M 44M 2025-12
AngioDynamics USD 44.78M 2.93M 2025-09
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Bio Techne USD 191.28M 3.16M 2025-12
Bio-Rad Laboratories USD 343.4M 1.9M 2025-09
Bruker USD 449.2M 69.8M 2025-12
Cerus USD 33.33M 8.66M 2024-12
Charles River Laboratories USD 271.96M 39.43M 2025-12
Danaher USD 3.97B 443M 2025-12
Dentsply International USD 443M 2M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Illumina USD 759M 26M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
IQVIA Holdings USD 1.12B 32M 2025-12
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Repligen USD 103.83M 3.32M 2025-12
Revvity USD 421.66M 47.06M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Trinity Biotech USD 6.47M 1.59M 2025-09
Waters USD 557.42M 97.44M 2025-12